Results 131 to 140 of about 1,463,708 (228)

Rational design of a Kappa opioid receptor peptide agonist with attenuated β-arrestin signaling. [PDF]

Nat Commun
Zhang H, Wang R, Shi P, Wang G, Zhu Q, He X, Xu Y, Yuan Q, Hu W, Wu K, Zheng Y, Zhou L, Liang J, Lv P, Xu Z, Yang F, Liu Y, Zhuang Y, Xu HE, Wang Y, Tian C.   +20 more
europepmc   +1 more source

Evidence that xylazine disrupts skin homeostasis by acting on epithelial cells through the kappa opioid receptor. [PDF]

Dis Model Mech
Robertson TF, Horn A, Smith FM, Huttenlocher A.   +3 more
europepmc   +1 more source

Kappa opioid receptor control of motivated behavior revisited. [PDF]

Neuropsychopharmacology
Farahbakhsh ZZ, Siciliano CA.
europepmc   +1 more source

Peptidomics and pharmacological profiling of Odontobuthus doriae (Buthidae) scorpion venom at the kappa opioid receptor. [PDF]

Sci Rep
Abdollahnia A, Bata BB, Fraunhofer A, Hermes J, Atashi J, Ghassempour A, Gruber CW.   +6 more
europepmc   +1 more source

Structural and dynamic insights into the biased signaling mechanism of the human kappa opioid receptor. [PDF]

Nat Commun
Suno-Ikeda C, Nishikawa R, Suzuki R, Yokoi S, Iwata S, Takai T, Ogura T, Hirose M, Tokuda A, Katamoto R, Inoue A, Asai E, Kise R, Sugita Y, Kato T, Nagase H, Mitsutake A, Saitoh T, Katayama K, Inoue A, Kandori H, Kobayashi T, Suno R.   +22 more
europepmc   +1 more source

A Cre Driver Line for Genetic Targeting of Kappa Opioid Receptor Expressing Cells. [PDF]

eNeuro, 2023
Paliarin F, Duplantis C, Jones AF, Cucinello-Ragland J, Basavanhalli S, Blaze E, Doré E, Neel AI, Sun H, Chen R, Edwards S, Gilpin NW, Messing RO, Maiya R.   +13 more
europepmc   +1 more source

Kappa Opioid Receptor Visualization in Oligodendrocyte-like Cells

Multiple sclerosis (MS) is an autoimmune, neurodegenerative disease that causes demyelination in the central nervous system. While multiple treatments have been established, none have been fully effective in relieving the debilitating symptoms.
Guirand, Anaelle
core  

Synthesis and Pharmacology of a Morphinan-Derived Dual Mu-Kappa Opioid Receptor Agonist Analgesic. [PDF]

ACS Chem Neurosci
Varga BR, Uprety R, Paul B, Knoll A, Ramos-Gonzalez N, Appourchaux K, Taylor T, Turgutalp B, Shinouchi R, Eans SO, Williams AK, Vasquez-Grinnell SG, Zaidi S, Nazarova AL, Varadi A, Le Rouzic V, Brown TG, Martinez S, Ansonoff M, Dardashti RN, Hunkele A, Subrath J, Welch M, Xu J, Rossi GC, Pintar J, Pasternak GW, Katritch V, McLaughlin JP, Pan YX, Majumdar S.   +30 more
europepmc   +1 more source

Kappa-Opioid Receptor Antagonism Prolongs the Antidepressant Effects of Ketamine in Adult Mice with Depression-like Behavior Induced by Adolescent Chronic Unpredictable Stress. [PDF]

Int J Mol Sci
Zivanovic A, Mitic M, Lukic I, Glavonic E, Adzic M, Ivkovic S.   +5 more
europepmc   +1 more source

Targeting the kappa opioid receptor for analgesia and antitumour effects. [PDF]

Br J Anaesth
Lambert DG, Mincer JS.
europepmc   +1 more source